Register
Login:
Share:
Email Facebook Twitter


RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum


Vernalis Share Price (VER)



Share Price Information for Vernalis (VER)


Share Price: 12.25Bid: 12.00Ask: 12.50Change: 0.00 (0.00%)No Movement on Vernalis
Spread: 0.50Spread as %: 4.17%Open: 12.50High: 12.50Low: 12.00Yesterday’s Close: 12.25

Vernalis Plc Ord 1P

Vernalis is listed in the FTSE AIM 100, FTSE AIM All-Share
Vernalis is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
12.25

Share Price SpacerBid
12.00

Share Price SpacerAsk
12.50

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
204,524

Share Price SpacerOpen
12.50

Share Price SpacerHigh
12.50

Share Price SpacerLow
12.00

Share Price SpacerClose
12.25

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 526.47m £63.18m 20,000

52 Week High 35.00 52 Week High Date 29-DEC-2016
52 Week Low 10.00 52 Week Low Date 12-OCT-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
10 72,489 100,000 -2.927 -4.10 0.00 0.00


London South East Users info for Vernalis




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

08-Dec-17
16:17:54
12.4033
180,000
Buy* 
12.00
12.50
22.33k
Trade Type:
Ordinary
Delayed publication

08-Dec-17
16:17:54
12.4033
180,000
Buy* 
12.00
12.50
22.33k
Trade Type:
Ordinary

08-Dec-17
16:17:54
12.4033
-180,000
Buy* 
12.00
12.50
-22.33k
Trade Type:
Ordinary
Deletion




View more Vernalis trades >>

Directors Deals for Vernalis (VER)
Trade DateActionNotifierPriceCurrencyAmountHolding
12-Oct-16Exercise of option
Trade Notifier Information for Vernalis plc
Ian Garland held the position of CEO at Vernalis plc at the time of this trade.
 Ian Garland
1GBX91,3101141167
12-Oct-16Exercise of option
Trade Notifier Information for Vernalis plc
David Mackney held the position of CFO at Vernalis plc at the time of this trade.
 David Mackney
1GBX48,630560833
12-Oct-16Sell
Trade Notifier Information for Vernalis plc
David Mackney held the position of CFO at Vernalis plc at the time of this trade.
 David Mackney
39.07GBX27,233533600
View more Vernalis directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
28 Nov '17Troajanver12.50No Opinion
a gaggle of chunky trades just there
10 Nov '17cadburyhillRE: ver12.75Strong Buy
well, you're right that risks definitely exist - that's why the chart looks like it does. we've been fretting over those risks all year.
but your '2/3p range in sight' stuff doesn't make any financial sense at all. it would imply a market cap of £10mn at 2p, which would mean the shareholders' equity would be worth 16% of the cash in the business. I've seen discounts to cash in the past (negative enterprise values) but nothing approaching that kind of level because cash is returned to… Read More
5 Nov '17legobrickgirlver12.50No Opinion
Hate to say this, but looks like 2/3p range is in sight.
The rejection by the FDA has hammered loss of earnings. Investors will now be wondering whether these drugs will be approved or not.
Forget about the current asset value of the company. If it cant make a profit the sp will continue to drop and the charts atm do not look promising, even though it has bounced of some support.
These types of shares are always a massive risk, but the rewards can be amazing.
If your looking to buy in now… Read More
12 Oct '17AtmosRE: FDA problem12.00No Opinion
Thanks for the update Cadburyhill, I guess that production issues are easier to fix. Given the current liquidity here a little good news would light the blue touch paper, I'm about 30% down at the minute but that's small fry considering the potential.
12 Oct '17cadburyhillRE: FDA problem12.00No Opinion
on the last call management said FDA letter was not one of product efficacy or biologics and there was no trial data resubmission issue. the problem was with Triss, the manufacturer and its production process.
but both Triss and Vernalis have been understandably vague as to what the specific problem is. They've also avoided making themselves hostages to fortune by giving us a deadline when it will be solved, except that they fully anticipate to be ready for next year's cough/cold season (but… Read More
12 Oct '17AtmosFDA problem11.50No Opinion
Anyone know if it was it a problem with the product or the production methods?
With the tangible asset value per share around 16p this is well oversold.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Vernalis (VER) >>

Please login or register to post a message on Share Chat.





Vernalis Plc Ord 1P home pageWebsite: Vernalis Plc Ord 1P
Website Description: Vernalis corporate website



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.